Alm disso, os pacientes constipados tambm podem se beneficiar com uso de alguns agentes que auxiliam a formao do bolo fecal, como o Psyllium e a Metilcelulose
Retatrutide is currently in Phase 3 clinical trials, which means it successfully passed Phase 1 (safety in healthy volunteers) and Phase 2 (efficacy and safety in target population)
Discover Our Full IV Therapy Menu From cellular recovery to athletic performance, we offer specialized protocols for every goal
Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals
This aging mechanism is closely related to various common diseases, including atherosclerosis, hypertension, chronic obstructive pulmonary disease, diabetes, and neurodegenerative disorders ( Current senolytic agents are primarily employed in cancer therapies, such as doxorubicin, trametinib, and cell cycle-targeting drugs like palbociclib ( Although studies have shown that FOXO4-DRI can block the binding of P53 to FOXO4, thereby promoting the apoptosis of senescent cells, the effect of FOXO4-DRI is not limited to alleviating the aging of certain organs